Filing Flows › InspireMD (NSPR) › Q2 2026
InspireMD (NSPR) Q2 2026 earnings results (second quarter 2026)
10-Q filed Aug 14, 2026
InspireMD (NSPR) reported revenue of $1.8M for the second quarter 2026 (Q2 2026), -0.4% from a year earlier and -48% from the quarter before. Operating margin was -815.6%, net loss $14.3M (808.8% of revenue).
InspireMD, Q2 2026: revenue $1.8M (-0.4% year over year), operating margin -815.6%, net loss $14.3M, operating cash flow −$10.9M. The chart follows the revenue to costs, profit and cash.
| Q2 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.8M | -48% | -0.4% |
| Operating profit | −$14.4M | — | — |
| Net earnings | −$14.3M | — | — |
| Operating cash flow | −$10.9M | — | — |
What changed
Revenue was $1.8M in Q2 2026, roughly flat year over year and down 48% from the previous quarter.
Operating costs exceeded revenue by $14.4M, an operating margin of -815.6%. The fastest-growing cost line was Sales & marketing (+25%). The quarter ended with a net loss of $14.3M, wider than the previous quarter's $13.7M loss.
Operating cash flow was −$10.9M. Non-cash charges added back $158K of depreciation and $2.2M of share-based compensation. Working capital and other items added $1.1M. Capital expenditures of $330K exceeded it, leaving free cash flow of −$11.2M.
Questions
What was InspireMD's revenue in the second quarter 2026?
InspireMD (NSPR) reported revenue of $1.8M for the second quarter 2026 (Q2 2026), -0.4% from a year earlier and -48% from the quarter before.
Was InspireMD profitable in the second quarter 2026?
Operating loss was $14.4M (-815.6% of revenue) and net loss $14.3M.
Source: InspireMD 10-Q on SEC EDGAR.